RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 34 filers reported holding RECRO PHARMA INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $5,211,000 | -8.8% | 646,552 | 0.0% | 0.10% | -14.5% |
Q3 2016 | $5,716,000 | +11.2% | 646,552 | 0.0% | 0.12% | +13.6% |
Q2 2016 | $5,140,000 | +33.2% | 646,552 | 0.0% | 0.10% | +24.1% |
Q1 2016 | $3,860,000 | -33.7% | 646,552 | 0.0% | 0.08% | -36.2% |
Q4 2015 | $5,819,000 | -25.2% | 646,552 | 0.0% | 0.13% | -36.3% |
Q3 2015 | $7,778,000 | – | 646,552 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samjo Capital LLC | 8,039,100 | $3,770,338 | 1.48% |
First Light Asset Management, LLC | 19,676,396 | $9,228,230 | 0.88% |
AWM Investment Company, Inc. | 10,266,144 | $4,814,822 | 0.71% |
Caligan Partners LP | 1,689,768 | $794,191 | 0.36% |
HighMark Wealth Management LLC | 484,985 | $227,458 | 0.19% |
Nantahala Capital Management | 1,250,000 | $586,250 | 0.05% |
Clear Harbor Asset Management, LLC | 938,847 | $440,319 | 0.05% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 4,249,229 | $1,992,888 | 0.03% |
TITLEIST ASSET MANAGEMENT, LLC | 210,148 | $98,559 | 0.02% |
ROYCE & ASSOCIATES LP | 3,285,082 | $1,540,703 | 0.02% |